4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000106
Senior Vice President, Finance sold 9,999 shares at an average $80.60 ($805,889)
- Senior Vice President, Finance acquired 9,999 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Agarwal Arjun Senior Vice President, Finance | 2026-10-12 | Option exercise 10b5-1 | +8,541 | $12.50 | $106,763 | 22,760 | D |
| Agarwal Arjun Senior Vice President, Finance | 2026-10-12 | Option exercise 10b5-1 | +1,458 | $34.39 | $50,141 | 24,218 | D |
| Agarwal Arjun Senior Vice President, Finance | 2026-10-12 | Sale 10b5-1 | −5,741 | $80.03 | $459,453 | 18,477 | D |
| Agarwal Arjun Senior Vice President, Finance | 2026-10-12 | Sale 10b5-1 | −2,100 | $80.76 | $169,596 | 16,377 | D |
| Agarwal Arjun Senior Vice President, Finance | 2026-10-12 | Sale 10b5-1 | −1,958 | $81.86 | $160,272 | 14,419 | D |
| Agarwal Arjun Senior Vice President, Finance | 2026-10-12 | Sale 10b5-1 | −200 | $82.84 | $16,567 | 14,219 | D |
| Derivatives | |||||||
| Agarwal Arjun Senior Vice President, Finance | 2026-10-12 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −8,541 | 76,376 | D | ||
| Agarwal Arjun Senior Vice President, Finance | 2026-10-12 | Option exercise · Employee Stock Option (right to buy) 10b5-1 | −1,458 | 56,875 | D | ||
| Open-market sales · 9,999 sh · avg $80.60 · $805,889 | |||||||
Loading xslF345X06/form4.xml…